Advertisement

Picture [iito] No Tracking 650x80px
Document › Details

AC Immune S.A.. (8/5/20). "Press Release: AC Immune Reports Q2 2020 Financial Results and Provides Business Update". Lausanne.

Organisations Organisation AC Immune S.A. (Nasdaq: ACIU)
  Organisation 2 Michael J. Fox Foundation for Parkinson’s Research
Products Product ACI-35.030 Alzheimer vaccine
  Product 2 SupraAntigen™ platform
Index term Index term Roche–AC Immune: therapeutic antibodies, 201206– license excl for anti-Tau program for Alzheimer’s disease to Genentech
     


   
Record changed: 2020-09-04

Advertisement

Picture EBD Group BIO-Europe 2020 Digital Event BEU2020 650x81

More documents for AC Immune S.A. (Nasdaq: ACIU)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture [iito] No Content Marketing 650x80px




» top